zidovudine has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lavie, A; Medin, JA; Neschadim, A; Sato, T; Yanagisawa, T | 1 |
| Burdick, R; Chaipan, C; Delviks-Frankenberry, KA; Hu, WS; Paprotka, T; Pathak, VK; Venkatachari, NJ | 1 |
2 other study(ies) available for zidovudine and Prostatic Neoplasms
| Article | Year |
|---|---|
The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer.
Topics: Analysis of Variance; Apoptosis; Bystander Effect; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Genes, Transgenic, Suicide; Genetic Therapy; HEK293 Cells; Humans; Male; Microscopy, Confocal; Nucleoside-Phosphate Kinase; Prodrugs; Prostatic Neoplasms; Reactive Oxygen Species; Zidovudine | 2013 |
Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Topics: Adenine; Animals; Antiviral Agents; Cell Line, Tumor; Cytidine Deaminase; Gammaretrovirus; Humans; Leukemia Virus, Murine; Male; Mice; Mutation; Organophosphonates; Prostatic Neoplasms; Pyrrolidinones; Raltegravir Potassium; Retroviridae Infections; Tenofovir; Tumor Virus Infections; Zidovudine | 2010 |